Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Higher testosterone harms sperm motility, while higher estradiol improves sperm survival.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Certain drugs that block specific enzymes can help treat prostate diseases.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Oral zinc sulphate reduces dark hair color in mice.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Centipeda minima extract helps hair grow by activating important growth signals and could be a promising hair loss treatment.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.